"Multiturn agents never follow a single script, so your tests can't either," explained Atin Sanyal, CTO and Co-founder of Galileo. "Luna-2's session metrics capture conversation quality, intent ...

The use of social media is contributing to declining attention spans, emotional volatility, and compulsive behaviors among ...

Anthropic, MaintainX and Persona are just some of the startups to make CRN’s list of the 10 hottest Software-as-a-Service ...

PATH has launched the largest study of its kind in Africa, recruiting 9,000 participants to test whether AI can help primary ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They ...

Monitoring AI's train of thought is critical for improving AI safety and catching deception. But we're at risk of losing this ability.

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...

Alphabet’s AI-powered drug discovery company, Isomorphic Labs, is preparing to take its first major leap into the real world.

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

When Microsoft AI announced one of its systems solved complex medical cases more accurately and cost-effectively than expert ...